OraSure Technologies, Inc. (OSUR) to Post Q2 2018 Earnings of $0.04 Per Share, Jefferies Group Forecasts

OraSure Technologies, Inc. (NASDAQ:OSUR) – Stock analysts at Jefferies Group cut their Q2 2018 EPS estimates for shares of OraSure Technologies in a research note issued to investors on Tuesday. Jefferies Group analyst B. Couillard now anticipates that the medical instruments supplier will earn $0.04 per share for the quarter, down from their prior estimate of $0.09. Jefferies Group currently has a “Hold” rating on the stock. Jefferies Group also issued estimates for OraSure Technologies’ FY2018 earnings at $0.27 EPS.

Other analysts have also recently issued research reports about the stock. BidaskClub cut shares of OraSure Technologies from a “strong-buy” rating to a “buy” rating in a report on Thursday. Zacks Investment Research cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a report on Tuesday. Canaccord Genuity reiterated a “buy” rating and issued a $24.00 price target on shares of OraSure Technologies in a report on Friday, February 2nd. Finally, ValuEngine cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $22.25.

Shares of OraSure Technologies (NASDAQ:OSUR) opened at $17.96 on Wednesday. The firm has a market cap of $1,048.00, a price-to-earnings ratio of 35.22, a P/E/G ratio of 4.82 and a beta of 1.43. OraSure Technologies has a fifty-two week low of $10.70 and a fifty-two week high of $23.01.

OraSure Technologies (NASDAQ:OSUR) last issued its earnings results on Wednesday, February 7th. The medical instruments supplier reported $0.12 EPS for the quarter, topping the consensus estimate of $0.11 by $0.01. The company had revenue of $52.00 million for the quarter, compared to the consensus estimate of $50.20 million. OraSure Technologies had a net margin of 18.52% and a return on equity of 13.09%. The firm’s revenue for the quarter was up 46.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.13 earnings per share.

A number of large investors have recently added to or reduced their stakes in OSUR. New York State Common Retirement Fund boosted its holdings in OraSure Technologies by 20.2% in the second quarter. New York State Common Retirement Fund now owns 61,800 shares of the medical instruments supplier’s stock valued at $1,067,000 after acquiring an additional 10,399 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of OraSure Technologies by 6.0% during the 2nd quarter. Northern Trust Corp now owns 761,667 shares of the medical instruments supplier’s stock valued at $13,146,000 after buying an additional 43,407 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of OraSure Technologies by 19.8% during the 2nd quarter. Vanguard Group Inc. now owns 5,352,832 shares of the medical instruments supplier’s stock valued at $92,390,000 after buying an additional 886,333 shares in the last quarter. California Public Employees Retirement System boosted its holdings in shares of OraSure Technologies by 14.0% during the 2nd quarter. California Public Employees Retirement System now owns 149,400 shares of the medical instruments supplier’s stock valued at $2,579,000 after buying an additional 18,400 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky boosted its holdings in shares of OraSure Technologies by 24.4% during the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 19,400 shares of the medical instruments supplier’s stock valued at $335,000 after buying an additional 3,800 shares in the last quarter. Institutional investors and hedge funds own 91.62% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “OraSure Technologies, Inc. (OSUR) to Post Q2 2018 Earnings of $0.04 Per Share, Jefferies Group Forecasts” was originally reported by Week Herald and is the property of of Week Herald. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://weekherald.com/2018/02/15/orasure-technologies-inc-osur-to-post-q2-2018-earnings-of-0-04-per-share-jefferies-group-forecasts.html.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply